In Conversation With... John H. Stone, MD MPH
“Steroids have a role in treating so many diseases - and yet, they do not cure any of them.” John H. Stone, MD MPH is a Professor of Medicine at Harvard Medical School, and the Edward A. Fox Chair in ...
TitAIN Trial Provides Hope to Giant Cell Arteritis Patients
A recent phase 2 safety and efficacy study of an anti-interleukin-17A monoclonal antibody for the treatment of giant cell arteritis patients suggests there may soon be another alternative to ...
The glucocorticoid toxicity index: Measuring change in glucocorticoid toxicity over time
Coping with steroid-toxicity has become an integral part of the treatment experience for patients with inflammatory disease for more than 70 years. With the development of new immunomodulatory ...
First new-drug approval in a decade for ANCA-associated vasculitis tackles steroid-toxicity
In October 2021, the US Food and Drug Administration issued its first new drug approval for antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) in a decade. The first-in-class ...
Curious about the true cost of steroid-toxicity?
Download our infographic today
